Abstract
Non-islet cell tumor hypoglycemia (NICTH) is uncommon. Many of the tumors associated with NICTH are mesenchymal tumors, although carcinomas are also involved in some cases. High serum levels of insulin-like growth factor II (IGF-II) have been associated with NICTH. Analysis of 4 pituitary tumors, 2 adrenocortical tumors, 42 solitary fibrous tumors, and 23 other mesenchymal tumors for IGF-II protein and mRNA showed that most mesenchymal tumors expressed IGF-II protein and mRNA, although only 4 of 48 patients had associated hypoglycemia. Tumor size was related to IGF-II production. Tumors less than 5 cm were usually negative for IGF-II mRNA, whereas 92.3% of tumors greater than 9 cm were positive for IGF-II mRNA.
These results show that IGF-II mRNA and protein can be readily detected in many tumors, even when the tumors are not associated with clinical hypoglycemia. The expression and production of this growth factor cannot accurately predict patients with clinical evidence of hypoglycemia.
Similar content being viewed by others
References
Nadler WH, Wolfer JA. Hepatogenic hypoglycemia associated with primary liver cell carcinoma. Arch Int Med 44:700–705, 1929.
Doege KW. Fibrosarcoma of the mediastinum. Ann Surg 92:955–960, 1930.
Crawford WH. Hypoglycemia with coma in a case of primary carcinoma of the liver. Am J Med Sci 181:496–502, 1931.
Daughaday WH. The pathophysiology of IGF-II hypersecretion in non-islet cell tumor hypoglycemia. Diabetes Rev 3:62–72, 1995.
Zapf J. Insulin-like growth factor binding proteins and tumor hypoglycemia. Trends Endocrinol Metab 6:37–42, 1995.
Marks V, Teale JD. Tumors producing hypoglycemia. Endocrine Related Cancer 5:111–129, 1998.
Watson RGP, Johnston CF, O’Hare MMT, Anderson JR, Wilson BG, Collins JSA, Sloan JM, Buchanon KD. The frequency of gastrointestinal endocrine tumors in a well-defined population. Northern Ireland 1970–1985. Quant J Med 72:647–657, 1989.
Klöppel G, In’t Veld PA, Komminoth P, Heitz PU. The Endocrine Pancreas. In Kovacs K and Asa SL (Eds) Functional Endocrine Pathology. Second Edition Blackwell Science INC. Malder MA 1998 pp 415–487.
Snowden JA, Greaves M, Page K. Reversal of diabetes associated with escape of myeloma: inappropriate IGF-II secretion. Br J Haematol 87:202–204, 1994.
Wasad T, Eguchi Y, Takagara S, Yao K, Hirata Y, Ishii S. Insulin autoimmune syndrome associated with benign monoclonal gammopathy. Evidence for monoclonal insulin autoantibodies. Diabetes Care 12:147–150, 1989.
Walters EG, Tavor JM, Denten RM, Walters G. Hypoglycemia due to an insulin-receptor antibody in Hodgkin’s disease. Lancet 1:241–243, 1987.
Batterlino T, Goto M, Zeller WP. Dexamethasone attenuates hypoglycemia in ten day old rats treated with TNF alpha. Res Comm Mol Pathol Pharmacol 92:149–154, 1996.
Lloyd RV, Jin L, Qian X, Zhang S, Scheithauer BW. Nitric oxide synthase in the human pituitary gland. Am J Pathol 146:86–94, 1995.
Lloyd RV, Jin L. Analysis of chromogranin/secretogranin messenger RNA in human pituitary adenomas. Diagn Mol Pathol 3:38–45, 1994.
Jansen M, van Schaik FM, van Toll H, van den Brande JL, Sussenbach JS. Nucleotide sequences of cDNAs encoding precursors of human insulin-like growth factor II (IGF-II) and an IGF-II variant. FEBS Lett 179:243–246, 1985.
England DM, Hocholzer L, McCarty MJ. Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases. Am J Surg Pathol 13:640–658, 1989.
Strewler GJ. Hormonal manifestations of malignancy. Williams Textbook of Endocrinology. Wilson JD, Foster DW, Kronenberg HM, Larsen PR (Eds). 9th Ed. WB Saunders Co. Philadelphia 1997 pp 1693–1710.
Hoog A, Norquist ACS, Hulting AL, Flakmer UG. High molecular weight IGF-II expression in a haemangiopericytoma associated with hypoglycemia. APMIS 105:469–482, 1997.
Katz LLE, Liu F, Baker B, Agus MSA, Nunn SE, Hintz RL, Cohen P. The effect of growth hormone treatment on the insulin-like growth factor axis in a child with non-islet cell tumor hypoglycemia. J Clin Endocrinol Metab 81:1141–1146, 1996.
Hoff AO, Vassilopoulou-Sellin R. The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia. Cancer 82:1585–1592, 1998.
Bommer G, Altenähr E, Kühnan J Jr, Klöppel G. Ultrastruture of hemangiopericytoma associated with paraneoplastic hypoglycemia. Z Krebsforsch 85:231–241, 1976.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lloyd, R.V., Erickson, L.A., Nascimento, A.G. et al. Neoplasms causing nonhyperinsulinemic hypoglycemia. Endocr Pathol 10, 291–297 (1999). https://doi.org/10.1007/BF02739771
Issue Date:
DOI: https://doi.org/10.1007/BF02739771